Luminist Labs

Acquired

Diagnostic platform for early detection of liver disease

What it does

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

Next to it in Healthcare and bio · non-invasive liver disease diagnostics

  • Kenota (formerly ExVivo Labs)Y Combinator S16

    Kenota is revolutionizing the way we test for disease

  • ACCELStars, Inc.Plug and Play

    The University of Tokyo Medical! Sleep with the world's highest accuracy with arm-mounted equipment-Captures awakening, and discover, treat, and prevent brain and mental illness. / 東大医発!腕装着機器で世界最高精度の技術で睡眠-覚醒を捉え、脳と心の病気等を早期発見・治療・予防する

  • HA-PPY Co., LtdPlug and Play

    Provision of devices and AI・IoT related to healthcare

  • InnoVeinY Combinator W16

    We cure intractable leg wounds with a replacement valve for veins.

  • Lucira HealthY Combinator W15

    Next generation infectious disease test kits

  • 株式会社スカイライト・バイオテックPlug and Play

    Skylight Biotech provides solutions for research, prevention and diagnosis in lifestyle-related diseases.

  • mFluiDXSOSV SOSV IndieBio 03

    Enabling molecular detection anywhere

  • HepatxY Combinator S18

    Replacing organ transplant with an infusion